MedPath

Cornea Preservation Time Study

Phase 4
Completed
Conditions
Transplant Success
Endothelial Keratoplasty
Endothelial Cell Density
Cornea Preservation Time
Interventions
Biological: Cornea tissue transplant
Registration Number
NCT01537393
Lead Sponsor
Case Western Reserve University
Brief Summary

The purpose of this study is to determine if the 3-year graft failure rate following endothelial keratoplasty performed with donor corneas with a preservation time of 8 to 14 days is non-inferior to the failure rate when donor corneas with a preservation time of 7 or fewer days are used.

Detailed Description

When the donor cornea is removed from the person who died, it is prepared for transplantation by an eye bank. The donor cornea is placed into a liquid that helps preserve the cornea until it is transplanted. The Food and Drug Administration (FDA) has approved storage of the cornea in this liquid for up to 14 days before the transplant. The purpose of this study is to see if the length of time the donor cornea is kept in the preservation liquid before the transplant affects the likelihood of the transplant being successful. We will follow participants for 3 years after transplant to see if there are any differences in transplant success or in the number of transplanted endothelial cells (the layer of cells that line the undersurface of the cornea) on the corneas that were preserved for 7 days or less compared to those preserved between 8 and 14 days. We have no reason to believe that there is any greater risk for transplant failure with either preservation time group.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
1174
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
8-14d Preservation Time GroupCornea tissue transplantSubjects in this arm will receive cornea tissue transplant with cornea tissue preserved for 8 to 14 days prior to transplant.
0-7d Preservation Time GroupCornea tissue transplantSubjects in this arm will receive cornea tissue transplant with cornea tissue preserved for 0 to 7 days prior to transplant.
Primary Outcome Measures
NameTimeMethod
Number of Eyes With Corneal Graft Failure Within 3 Years of SurgeryStudy eye will be assessed for this outcome for 3 years following surgery

Graft failure, defined as the occurrence of one of the following within 3 years of surgery:

* Regrafting of the study eye for any reason

* Cornea which remains cloudy without clearing, according to the following:

1. cloudy cornea on the first postoperative day which does not clear within 8 weeks OR

2. cloudy cornea which was initially clear postoperatively but becomes and remains cloudy for 3 months without clearing.

Endothelial Cell Density (ECD)3 years from surgery

Endothelial cell density at 3 years from surgery, conditional on graft survival at 3 years from surgery.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (40)

NorthShore University Health System

🇺🇸

Glenview, Illinois, United States

Ohio State Medical Center

🇺🇸

Columbus, Ohio, United States

Cincinnati Eye Institute

🇺🇸

Cincinnati, Ohio, United States

Bascom Palmer Eye Institute

🇺🇸

Miami, Florida, United States

Keck Medical Center

🇺🇸

Beverly Hills, California, United States

Eye Care of San Diego

🇺🇸

San Diego, California, United States

Jules Stein Eye Institute

🇺🇸

Los Angeles, California, United States

Woolfson Eye Institute

🇺🇸

Atlanta, Georgia, United States

Center for Sight

🇺🇸

Sarasota, Florida, United States

Eye Consultants of Atlanta

🇺🇸

Atlanta, Georgia, United States

University of Illinois Eye and Eye

🇺🇸

Chicago, Illinois, United States

University of Iowa Hospitals and Clinics

🇺🇸

Iowa City, Iowa, United States

University of Kentucky Ophthalmology

🇺🇸

Lexington, Kentucky, United States

Mid-Atlantic Cornea Consultants

🇺🇸

Baltimore, Maryland, United States

Ophthalmic Consultants of Boston

🇺🇸

Boston, Massachusetts, United States

Johns Hopkins/Wilmer Eye Institute

🇺🇸

Baltimore, Maryland, United States

Eye Consultants of Maryland

🇺🇸

Owings Mills, Maryland, United States

Verdier Eye Center

🇺🇸

Grand Rapids, Michigan, United States

University of Michigan/Kellogg Eye Center

🇺🇸

Ann Arbor, Michigan, United States

Michigan Cornea Consultants

🇺🇸

Southfield, Michigan, United States

Minnesota Eye Consultants

🇺🇸

Bloomington, Minnesota, United States

Mercy Medical Research Institute

🇺🇸

Springfield, Missouri, United States

Ophthalmology Associates

🇺🇸

Saint Louis, Missouri, United States

University Hospitals Case Medical Center Eye Institute

🇺🇸

Cleveland, Ohio, United States

New York Eye and Ear Infirmary

🇺🇸

New York, New York, United States

Cornea Consultants of Albany

🇺🇸

Slingerlands, New York, United States

Northeast Ohio Eye Surgeons

🇺🇸

Kent, Ohio, United States

Ophthalmic Partners of PA

🇺🇸

Bala-Cynwyd, Pennsylvania, United States

Medical Eye Center

🇺🇸

Medford, Oregon, United States

Central Pennsylvania Eye Institute

🇺🇸

Hershey, Pennsylvania, United States

Sadeer Hannush, MD

🇺🇸

Langhorne, Pennsylvania, United States

Corneal Associates, PC, Wills Eye Institute

🇺🇸

Philadelphia, Pennsylvania, United States

Cornea Associates of Texas

🇺🇸

Dallas, Texas, United States

Eye Associates Northwest

🇺🇸

Seattle, Washington, United States

Dean Medical Center

🇺🇸

Madison, Wisconsin, United States

Focal Point Vision

🇺🇸

San Antonio, Texas, United States

University of Utah, Moran Eye Center

🇺🇸

Salt Lake City, Utah, United States

University of California, San Francisco

🇺🇸

San Francisco, California, United States

Mayo Clinic

🇺🇸

Rochester, Minnesota, United States

Devers Eye Institute

🇺🇸

Portland, Oregon, United States

© Copyright 2025. All Rights Reserved by MedPath